From CGT Innovation to Investment Readiness: Navigating the Nordic Support Landscape
On 27 November 2026, ATMP Sweden hosts a one-hour online panel on CGT investment readiness. The focus is on what it takes to turn a cell and gene therapy discovery into an investable venture. Topics include funding gaps, the valley of death and the role of the Nordic support system.
The panel features speakers from LU Innovation (Lund University), KI Innovations (Karolinska Institutet) and the GeneCellNano Flagship (University of Eastern Finland). Daphne Hingert Aldridge of CCRM Nordic moderates. Each panellist first presents their organisation, and the session ends with an open Q&A.
The webinar runs on Microsoft Teams. It leads up to the Cell & Gene Therapy Investor Forum at Campus Flemingsberg, Stockholm, on 30 November. Participation requires registration.
